Skip to content

Exploratory Study on identification of the position of the lung cancer Using PINPOINT Endoscopic Fluorescence Imaging System in thoracic Surgery

Exploratory Study on identification of the position of the lung cancer Using PINPOINT Endoscopic Fluorescence Imaging System in thoracic Surgery - Study on identification of the position of the lung cancer Using PINPOINT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029631
Enrollment
20
Registered
2017-11-01
Start date
2017-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

ICG is intravenously administered at 0.25 - 0.5 mg / kg between 24 hours before the start of surgery and start of the operation. We will confirm accumulation of ICG in lung cancer with the ICG Endosco

Sponsors

Shiga University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Cases with age => 20 years (no upper limit is provided). 2.Cases in which functions of major organs are preserved. 3.Cases that an operation under the general anesthesia is possible. 4.A well-informed written consent was obtained from the patient

Exclusion criteria

Exclusion criteria: 1.Pregnant or potentially women, nursing women 2.Past history of the open thoracotomy. 3.A patient with a history of hypersensitivity to the components of ICG or a patient with a history of iodine hypersensitivity. 4.Patients with psychiatric diseases. 5.Patients with severe or complicated medical conditions, not allowing participation into this protocol.

Design outcomes

Primary

MeasureTime frame
Visibility of ICG accumulation in lung cancer by PINPOINT Endoscopic Fluorescence Imaging System

Countries

Japan

Contacts

Public ContactYasuhiko Ohshio

Shiga University of Medical Science Department of Chest Surgery

yasuhiko@belle.shiga-med.ac.jp077-548-2244

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026